Taft Chicago Pharmaceutical and Life Sciences Litigation attorneys Stephen Auten and Jaimin Shah along with Sinchan Shah of Amneal Pharmaceuticals Pvt. Ltd. published “For Now, Competitive Generic Therapy Exclusivity is a Mirage” for Law360. The article discusses issues with competitive generic therapy exclusivity enacted in the Food and Drug Reauthorization Act of 2017.